Search Results - "Boureille, A"

Factors associated with pregnancy outcome in anti‐TNF treated women with inflammatory bowel disease by Seirafi, M., Vroey, B., Amiot, A., Seksik, P., Roblin, X., Allez, M., Peyrin‐Biroulet, L., Marteau, P., Cadiot, G., Laharie, D., Boureille, A., De Vos, M., Savoye, G., Rahier, J.‐F., Carbonnel, F., Bonaz, B., Colombel, J.‐F., Bouhnik, Y.

“…Summary Background The safety of anti‐tumour necrosis factor (TNF) agents during pregnancy is a major concern for child‐bearing women and physicians. Aim To…”
Get full text

Risk of anti-TNF therapy on pregnancy, breastfeeding, live vaccines and related information in patients with inflammatory bowel disease: Real-world data from a nationwide study by Bendaoud, S., Nahon, S., Beaugerie, L., Gornet, J.M., Wils, P., Amiot, A., Peyrin-Biroulet, L., Abitbol, V., Hébuterne, X., Altwegg, R., Rosa, I., Amil, M., Heluwaert, F., Plastaras, L., Stefanescu, C., Quentin, V., Antoni, M., Bideau, K., Boualit, M., Cuillerier, E., Locher, C., Skinazi, F., Boureille, A., Buisson, A., Simon, M.

“…Anti-TNF are usually maintained during pregnancy in patients with inflammatory bowel disease (IBD) but safety is still a concern for them. To provide data on…”
Get full text

Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine by Vernier-Massouille, G, Cosnes, J, Lemann, M, Marteau, P, Reinisch, W, Laharie, D, Cadiot, G, Bouhnik, Y, De Vos, M, Boureille, A, Duclos, B, Seksik, P, Mary, J-Y, Colombel, J-F

“…Aim: To assess the characteristics and clinical course of nodular regenerative hyperplasia (NRH) in patients with inflammatory bowel disease treated with…”
Get full text

Adalimumab for patients with Crohn’s disease complicated by intra-abdominal abscess: a multicentre, prospective, observational cohort study by Pineton de Chambrun, G, Pariente, B, Seksik, P, Altwegg, R, Vuitton, L, Stefasnescu, C, Nancey, S, Aubourg, A, Serrero, M, Peyrin-Biroulet, L, Filippi, J, Viennot, S, Abitbol, V, Boualit, M, Boureille, A, Moreau, J, Buisson, A, Roblin, X, Nachury, M, Zappa, M, Lambert, J, Bouhnik, Y

“…Abstract doi:10.1093/ecco-jcc/jjy222 Abstract P528 from the ‘Poster presentations’ section of the main abstract book has been withdrawn and re-inserted as…”
Get full text

Mo1609 Colonic Mucosal Healing in IBD Patients During Clinical Remission. a Prospective Study Using Colonoscopy, Confocal LASER Endomicroscopy (CLE) and Histology by Coron, Emmanuel, Boureille, A, Branche, Julien, Moussata, Driffa, Mosnier, Jean-François, Le Rhun, Marc, Matysiak-Budnik, Tamara, Galmiche, Jean Paul

Get full text

Su1223 Efficacy and Safety of Adalimumab 80mg Weekly in Crohn's Disease by Bouguen, Guillaume, Laharie, David, Nancey, Stéphane, Hebuterne, Xavier, Flourie, Bernard, Filippi, Jérôme, Roblin, Xavier, Trang, Caroline, Boureille, A, Babouri, Abdenour, Bretagne, Jean-François, Siproudhis, Laurent, Peyrin-Biroulet, Laurent

Get full text

T1196 Common Molecular Links Between Chronic Inflammation in Ulcerative Colitis and Colon Cancer Identified by Confocal Endomicroscopy and Molecular Imaging: Mitochondrial DNA Mutations, Dysregulated Importin α and Upregulated COX2 by Coron, Emmanuel, Rhun, Marc Le, Boureille, A, Galmiche, Jean-Paul, Mosnier, Jean-François, Ahluwalia, Amrita, Sandor, Zsuzsa, Tarnawski, Andrzej S, Matysiak-Budnik, Tamara

Get full text

Ovarian reserve evaluation in women of reproductive age suffering from inflammatory bowel diseases by Freour, T, Masson, D, Boureille, A, Dejoie, T, Jean, M, Barriere, P

Get full text

DOP89 Impact of biologics on the risk of early postoperative complications in Crohn’s disease: a French nationwide study by Fumery, M, Nancey, S, Nachury, M, Allez, M, Rouillon, C, Boureille, A, Altwegg, R, Serrero, M, Vuitton, L, Bouguen, G, Abitbol, V, Boualit, M, Biron, A, Panis, Y, Laharie, D, Amiot, A, Simon, M, Caillo, L, Hébuterne, X, Vidon, M, Benezech, A, Elgharabawy, Y, Peyrin-biroulet, L

“…Abstract Background While the effect of anti-TNFs on postoperative outcomes in patients with Crohn’s disease (CD) has been widely studied, the impact of…”
Get full text

P439 Patient’ recruitment for a Phase 3 inflammatory bowel disease (IBD) programme is significantly increased when accessing the CT-SCOUT™ platform by Bouhnik, Y, Roblin, X, Mrad, R, Hebuterne, X, Laharie, D, Tanasa Stefanescu, C, Nancey, S, Boureille, A, Amiot, A, Sebbah, N, Peyrin Biroulet, L

“…Abstract Background The main issue when validating new molecules in the field of IBD is insufficient patient recruitment into clinical trials, resulting in a…”
Get full text

P404 Persistence of subcutaneous infliximab after switching from intravenous in a French national cohort of IBD patients in remission by Mathieu, N, Riviere, P, Heluwaert, F, Hébuterne, X, Chupin, A, Bouguen, G, Vuitton, L, Allez, M, Montuclard, C, Nachury, M, Nancey, S, Amélie, B, Gilletta, C, Abitbol, V, Altwegg, R, de Maissin, A, Plastaras, L, Ah Soune, P, Boureille, A, Bouhnik, Y, Seksik, P, Chanteloup, E, marion, S, Uzzan, M, Andrau, P, Rouillon, C, Arondel, Y, Peyrin Biroulet, L, Laharie, D

“…Abstract Background Subcutaneous infliximab (IFX-SC) was launched in France for the treatment of patients with inflammatory bowel disease (IBD) in 2021…”
Get full text

P528 Adalimumab for patients with Crohn’s disease complicated by intra-abdominal abscess: a multi-centre, prospective, observational cohort study by Pineton de Chambrun, G, Pariente, B, Seksik, P, Altwegg, R, Vuitton, L, Stefasnescu, C, Nancey, S, Aubourg, A, Serrero, M, Peyrin-Biroulet, L, Filippi, J, Viennot, S, Abitbol, V, Boualit, M, Boureille, A, Moreau, J, Buisson, A, Roblin, X, Nachury, M, Zappa, M, Lambert, J, Bouhnik, Y

“…Abstract Background Management of intra-abdominal abscess complicating Crohn’s disease (CD) is challenging. Surgery with delayed intestinal resection is often…”
Get full text

DOP63 Adalimumab for patients with Crohn’s disease complicated by intra-abdominal abscess: a multi-centre, prospective, observational cohort study by Pineton de Chambrun, G, Pariente, B, Seksik, P, Altwegg, R, Vuitton, L, Stefasnescu, C, Nancey, S, Aubourg, A, Serrero, M, Peyrin-Biroulet, L, Filippi, J, Viennot, S, Abitbol, V, Boualit, M, Boureille, A, Moreau, J, Buisson, A, Roblin, X, Nachury, M, Zappa, M, Lambert, J, Bouhnik, Y

“…Abstract Background Management of intra-abdominal abscess complicating Crohn’s disease (CD) is challenging. Surgery with delayed intestinal resection is often…”
Get full text

P310 Development of a new clinico-biological score associated with disease activity in patients with inflammatory bowel disease treated with thiopurine by Williet, N., Nancey, S., Boureille, A., Altwegg, R., Cadiot, G., Nachury, M., Laharie, D., Filippi, J., Sparrow, M., Nahon, S., Bouguen, G., Aygalenq, P., Viennot, S., Bonnaud, G., Dupin, M., Boukhadra, N., Del Tedesco, E., Roblin, X.

Get full text

P347 Vedolizumab for primary sclerosing cholangitis associated with inflammatory bowel disease: A multicentre cohort study from the GETAID by Caron, B, Peyrin-Biroulet, L, Nachury, M, Bouhnik, Y, Seksik, P, Bouguen, G, Caillo, L, Laharie, D, Carbonnel, F, Altwegg, R, Reenaers, C, Serrero, M, Boureille, A, Nancey, S, Filippi, J, Abitbol, V, Savoye, G, Vuitton, L, Viennot, S, Fumery, M, Reymond, M, Bronowicki, J P, Reimund, J -M, Amiot, A

“…Abstract Background Whether vedolizumab is effective and safe as a treatment of primary sclerosing cholangitis (PSC) is unclear. Methods We performed a…”
Get full text

P817 Live-vaccines and lactation in newborn exposed in utero to anti-TNF: A multi-centre French experience in inflammatory bowel disease by Bendaoud, S, Nahon, S, Gornet, J -M, Pariente, B, Beaugerie, L, Abitbol, V, Peyrin-Biroulet, L, Buisson, A, Hebuterne, X, Altwegg, R, Amil, M, Rosa, I, Heluwaert, F, Plastaras, L, Antony, M, Boureille, A, Bouhnik, Y, Quentin, V, Aubourg, A, Boualit, M, Bideau, K, Cuillerier, E, Locher, C

“…Abstract Background Anti TNF cross placenta during pregnancy and are detectable in the newborn in the first 6 months at least. European consensus recommends to…”
Get full text

Vedolizumab for primary sclerosing cholangitis associated with inflammatory bowel disease: A multicentre cohort study from the GETAID by Caron, Benoît, Peyrin-Biroulet, L., Nachury, M., Bouhnik, Y., Seksik, P., Bouguen, G., Caillo, L., Laharie, D., Carbonnel, F., Altwegg, R., Reenaers, C., Serrero, M., Boureille, A., Nancey, S., Filippi, J., Abitbol, V., Savoye, G., Vuitton, L., Viennot, S., Fumery, Mathurin, Reymond, M., Bronowicki, J. P., Reimund, J. -M., Amiot, A.

Get full text

P522 Efficacy and safety of adalimumab 80 mg weekly in Crohn's disease by Bouguen, G., Laharie, D., Nancey, S., Hébuterne, X., Flourié, B., Filippi, J., Roblin, X., Trang, C., Boureille, A., Babouri, A., Bretagne, J.-F., Siproudhis, L., Peyrin-Biroulet, L.

Get full text

Multidrug resistance gene‐1 polymorphisms and resistance to cyclosporine a in patients with steroid resistant ulcerative colitis by Daniel, Fady, Loriot, Marie‐Anne, Seksik, Philippe, Cosnes, Jacques, Gornet, Jean‐Marc, Lémann, Marc, Fein, Francine, Vernier‐Massouille, Gwenola, De Vos, Martine, Boureille, Arnaud, Treton, Xavier, Flourié, Bernard, Roblin, Xavier, Louis, Edouard, Zerbib, Frank, Beaune, Philippe, Marteau, Philippe

“…Background: Cyclosporine A (CsA) is inconstantly effective in inducing remission in acute attacks of ulcerative colitis (UC) not responding to steroids. This…”
Get full text

Insuffisance cardiaque de novo sous anti-TNFa : à propos de 3 cas et revue de la littérature by Perrin, F., Néel, A., Masseau, A., Boureille, A., Berthelot, JM, Piriou, N., Hamidou, M.

Get full text